SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-11-045066
Filing Date
2011-08-09
Accepted
2011-08-09 06:02:44
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a11-13997_110q.htm 10-Q 1015709
2 EX-10.1 a11-13997_1ex10d1.htm EX-10.1 60488
3 EX-31.1.1 a11-13997_1ex31d1d1.htm EX-31.1.1 13247
4 EX-31.2.1 a11-13997_1ex31d2d1.htm EX-31.2.1 13391
5 EX-32.1 a11-13997_1ex32d1.htm EX-32.1 6962
  Complete submission text file 0001104659-11-045066.txt   4501285

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT osir-20110630.xml EX-101.INS 749213
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT osir-20110630.xsd EX-101.SCH 15615
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT osir-20110630_cal.xml EX-101.CAL 40738
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT osir-20110630_def.xml EX-101.DEF 90922
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT osir-20110630_lab.xml EX-101.LAB 250306
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT osir-20110630_pre.xml EX-101.PRE 119068
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32966 | Film No.: 111018814
SIC: 2836 Biological Products, (No Diagnostic Substances)